IL-17 has been shown to enhance NK cell recruitment in human esophageal cancer through tumor-derived chemokines and NK cell cytotoxicity through the increased expression of activating receptors, perforin, granzyme B, TNF-α, and IFN-γ (103). The gene discussed is IFNG; the disease is neoplasm.